Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability

Table 1

Results of analysis of variance (ANOVA) for repeated measures with Bonferroni correction for multiple comparisons, performed with rating scales for BPD-related symptoms and social functioning in patients treated with paliperidone ER (N = 14).

Variable		Mean	SD	SE	P
CGI severity item score	T0	4.50	0.51	0.12	0.001
	T1	4.28	0.46	0.11
	T2	3.72	0.46	0.11
BPRS score	T0	42.28	4.92	1.16	0.001
	T1	38.28	4.61	1.09
	T2	35.11	3.86	0.91
HARS score	T0	18.17	4.20	0.99	0.262
	T1	13.83	4.63	1.09
	T2	15.50	4.90	1.16
HDRS score	T0	10.50	3.88	0.92	0.120
	T1	8.67	2.61	0.62
	T2	8.39	2.28	0.54
SOFAS score	T0	48.78	6.26	1.47	0.001
	T1	53.06	5.67	1.34
	T2	59.33	6.28	1.48